Skip to main content

Table 2 HRCT findings, histopathology and stages of LC in patients with LC-IPF (n = 34)

From: Prevalence, risk factors, and impact of lung Cancer on outcomes of idiopathic pulmonary fibrosis: a study from the Middle East

Characteristic

No. (%)

Time of LC diagnosis

 At the time of IPF diagnosis

12 (35.3)

 After IPF diagnosis

22 (64.7)

Location

 Centrala

9 (26.5)

 Peripheral

25 (73.5)

Lobes of the lung

 Upper lobes

10 (29.5)

 Middle lobe

1 (2.9)

 Lower lobes

23 (67.6)

HRCT background

 Fibrotic backgroundb

23 (67.6)

 Nonfibrotic background

11 (32.4)

Histopathology

 Squamous cell carcinoma

15 (44)

 Adenocarcinoma

14 (41)

 Adenosquamous carcinoma

2 (6)

 large cell carcinoma

2 (6)

 Undifferentiated carcinoma

1 (3)

Stage

 I

8 (23.3)

 II

5 (15.0)

 III

9 (26.4)

 IV

12 (35.3)

  1. LC-IPF combined lung cancer and idiopathic pulmonary fibrosis, HRCT high-resolution computed tomography
  2. aCentral; the tumor was considered central when located in an area 3 cm far from the pleura
  3. bFibrotic background; includes reticular distortion, ground-glass opacity, and honeycombing